CAR T-cell therapies involve genetically modifying a patient's T cells to express a receptor specific to cancer cells. These engineered T cells are then expanded and reintroduced into the patient to target and destroy cancer cells. CAR T-cell therapies have shown significant success in treating certain types of blood cancers.
